Home › Hodgkin Lymphoma › Wisconsin › Madison
Hodgkin Lymphoma clinical trials in Madison, WI
4 studies for Hodgkin Lymphoma are looking for participants at sites in and around Madison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
RecruitingPhase 1
- University of Wisconsin Carbone Cancer Center, Madison
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- University of Wisconsin - Madison, Madison
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
RecruitingPhase 1/2
- University of Wisconsin, Madison
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
RecruitingPhase 1
- University of Wisconsin Carbone Cancer Center, Madison
About Hodgkin Lymphoma
Hodgkin lymphoma is a type of lymphoma, cancer of the lymph system. It is serious but can usually be cured if found and treated early. Learn more.
More about Hodgkin Lymphoma on MedlinePlus
Hodgkin Lymphoma trials in other cities
- Houston, TX14 studies
- New York City, NY11 studies
- Boston, MA9 studies
- Baldwin Park, CA9 studies
- Miami, FL8 studies
- Memphis, TN7 studies
- Philadelphia, PA6 studies
- Atlanta, GA5 studies
- Mountain View, CA5 studies
- Greenburgh, NY5 studies
- Durham, NC4 studies
- Milwaukee, WI4 studies
Other studies in Madison
- Prostate Cancer29 studies
- Colorectal Cancer23 studies
- Breast Cancer22 studies
- Metastatic Cancer21 studies
- Acute Myeloid Leukemia16 studies
- Non-Small Cell Lung Cancer16 studies
- Melanoma15 studies
- Cancer (all types)14 studies
- Ovarian Cancer13 studies
- Stomach Cancer11 studies
- Pancreatic Cancer10 studies
- Lung Cancer10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.